Mark Sliwkowski
机构: Distinguished Staff Scientist (Genentech, retired). Denali Therapeutics
每年引用次数
引用次数
引用: 47,542
H-指数: 84
I10-指数 : 187
出版物: 346
Antibodies to human ErbB4
Mary E Gerritsen , Mark X Sliwkowski
4
2010
Anti-HER2 antibodies and immunoconjugates
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
3
2020
Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
3
2019
Anti-HER2 antibodies and immunoconjugates
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
3
2019
Anti-her antibodies
Germaine Fuh , Lauric Haber , Gabriele Schaefer , Mark X Sliwkowski
3
2014
The dual action antibody MEHD7945A targeting EGFR and HER3 enhances chemotherapy induced cytotoxicity in vitro and in vivo
Lisa M Crocker , Carter Fields , Lily Shao , Mark X Sliwkowski
Cancer Research 72 ( 8_Supplement) 1212 -1212
2
2012
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
Svetlana O Doronina , Peter D Senter , Brian E Toki , Allen J Ebens
1
2016
Ligand-Independent HER2/HER3/PI3K complex is disrupted by Trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941 (vol 15, pg 429, 2009)
Teemu T Junttila , Robert W Akita , Kathryn Parsons , Carter Fields
Cancer Cell 20 ( 6) 818 -818
1
2011
Monomethylvaline compounds capable of conjugation to ligands
Svetlana O Doronina , Peter D Senter , Brian E Toki , Allen J Ebens
1
2005
Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
Mark X Sliwkowski , Scott Holden , Stuart Lutzker , Jay Tibbitts
2023
Anti-HER2 Antibodies and Immunoconjugates
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
2023
Anti-her2 antibodies and immunoconjugates
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
2021
Anti-her2 antitela i imunokonjugati
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
2020
Anticorps et immunoconjugués anti-her2
Mark Dennis , Thomas Harden Pillow , Xiaocheng Chen , Jagath Reddy Junutula
2020
Combinations of an anti-her2 antibody-drug conjugate and 5-fu, anti-vegf antibody, carboplatin or abt-869 and methods of use
Leanne Berry , Gail Lewis Phillips , Mark X Sliwkowski
2020
Immunoconjugates Comprising Anti-HER2 Antibodies and Pyrrolobenzodiazepines
Xiaocheng Chen , Mark Dennis , Jagath Reddy Junutula , Gail Lewis Phillips
2020
Combinations of an anti-her2 antibody-drug conjugate and lapatinib, and methods of use
Leanne Berry , Gail Lewis Phillips , Mark X Sliwkowski
2020
Assay for cancer cells based on the use of auristatin conjugates with antibodies
Svetlana O Doronina , Peter D Senter , Brian E Toki , Allen J Ebens
2019
Intermediate for conjugate preparation comprising auristatin derivatives and a linker
Svetlana O Doronina , Peter D Senter , Brian E Toki , Allen J Ebens
2018
Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
Leanne Berry , Gail Lewis Phillips , Mark X Sliwkowski
2018